CV Imaging Perspective

• Alzheimer's Disease: Hope on the Horizon: The Winding Road to Approval   Experts at Butler Hospital in Providence, Rhode Island, discuss the bumpy road to the FDA's accelerated approval of aducanumab.
  Medscape TV, May 23, 2022
• Management of Post-COVID Cardiac Symptoms   How primary care physicians can evaluate and counsel patients with persistent cardiovascular symptoms after COVID.
  Medscape Family Medicine, May 20, 2022
• Colorectal Cancer e-Tumor Boards: Case 2: Colorectal Liver Metastases   The case focuses on a 32-year-old man whose colonoscopy showed a non-bleeding mass about 2-3 cm above the anal verge with some symptoms of mild partial obstruction. His staging imaging demonstrates multiple liver lesions, a mid-rectal thickening, and some small pulmonary nodules.
  Medscape, May 18, 2022
• The Case for Post-COVID Steroids   Dr F. Perry Wilson cautions against changing practice on the basis of a single study.
  Medscape, May 12, 2022
• Five New Neurology Studies: Possible Breakthroughs, Some Failures   Dr Christoph Diener on promising early results in muscular dystrophy and Creutzfeldt-Jakob disease, and discouraging ones for aducanumab.
  Medscape Neurology, May 09, 2022
• Recurrent Atypical Chest Pain in a 62-Year-Old Woman A 62-year-old woman presents with atypical chest pain and mild shortness of breath manifesting with recurring, fleeting, dull, nonradiating pain, seemingly caused by high-stress environments. What's going on?
  American College of Cardiology & Medscape , May 09, 2022
• HRS 2022 Taking Cardiac Pacing From Boring to Super-Cool Ablation has hogged the electrophysiology spotlight recently, but three presentations at the 2022 Heart Rhythm Society meeting put cardiac pacing on the comeback trail.
  theheart.org on Medscape, May 09, 2022
• Hands-on for HF: New Considerations for Cardiac Rehab   Drs Daniel Forman and Gordon Reeves discuss how the REHAB-HF trial results inform potential new directions in exercise training for both HFpEF and HFrEF patients that may be beneficial.
  American College of Cardiology & Medscape , May 05, 2022
• Key Points From the New Heart Failure Guidelines   Dr Ileana Piña discusses the 2022 AHA/ACC/HFSA heart failure guidelines and how they compare with the European guidelines and recent data on heart failure.
  theheart.org on Medscape, May 04, 2022
• Beyond Glucose: Reducing CVD in Patients With Diabetes: Integrative Approach   Cardiologists discuss the multiple evidence-based treatment modalities, such as acupuncture, included in the UC Irvine preventive cardiology program.
  Medscape TV, April 26, 2022
• What's the Most Likely Cause of This Man's Severe Headaches? His headache is worse when he stands, and resolves when he lies down. Valsalva maneuver makes the headache much worse.
  Medscape Internal Medicine, April 20, 2022
• Through a Different Lens: Redefining Heart Failure   Leading cardiologists from Northwestern Medicine discuss patient challenges and treatment breakthroughs for persons diagnosed with heart failure with preserved ejection fraction.
  Medscape TV, April 20, 2022
• Alzheimer's Disease: Hope on the Horizon: Antibody Therapies: Hopes and Doubts   Neurologists discuss how mixed results from clinical trials of beta-amyloid–targeting antibodies are shaping insights into the Alzheimer's disease process.
  Medscape TV, April 14, 2022
• Are All Medical Errors Now Crimes? The Nurse Vaught Verdict   Drs Robert Glatter, Jane Barnsteiner, and Megan Ranney discuss medical errors related to medication dispensing, inspired by a recent event.
  Medscape Emergency Medicine, April 13, 2022
• Contrast-Associated Acute Kidney Injury Is a Meaningless Endpoint A change in lingo and a new risk score don't diminish this nephrologist's skepticism about the clinical significance of contrast-associated nephropathy.
  theheart.org on Medscape, April 12, 2022
• Episode 2: How to Quickly Spot and Manage Psoriasis Comorbidities   What's the best way to screen for common comorbidities in patients with psoriasis, and how do the experts respond when clues of systemic disease show up?
  Medscape, April 05, 2022
• ACC 2022 Percutaneous Left Atrial Appendage Occlusion: Promise vs Reality The selling point of percutaneous left atrial appendage occlusion is to prevent stroke while avoiding the bleeding risk of antithrombotics. The data paint a different picture, writes John Mandrola, MD.
  theheart.org on Medscape, April 04, 2022
• ACC 2022 Mavacamten in HCM: Reasons for Optimism and Caution The novel drug helped patients avoid septal reduction therapy in the short term and approval looks likely, but more details and longer-term safety data will be needed before broader use, writes John Mandrola, MD.
  theheart.org on Medscape, April 02, 2022
• Apr 1 2022 This Week in Cardiology   Coronary CTA, semaglutide, coronary artery calcium, exercise, and an ACC and EHRA preview are the topics discussed by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, April 01, 2022
• ACC 2022 Mandrola Previews ACC 2022 Studies on sodium restriction, fractional flow reserve, and strategies to improve patient and clinician behavior intrigue, but the best part of ACC22 is that it's largely in-person, writes John Mandrola, MD.
  theheart.org on Medscape, March 29, 2022